for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

J B Chemicals and Pharmaceuticals Ltd

JBCH.NS

Latest Trade

388.65INR

Change

-7.70(-1.94%)

Volume

77,473

Today's Range

385.10

 - 

397.20

52 Week Range

272.30

 - 

411.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

India's J B Chemicals And Pharmaceuticals Sept-Qtr Consol Net Profit Rises

Nov 12 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::SEPT-QUARTER CONSOL NET PROFIT 936.2 MILLION RUPEES VERSUS 513.3 MILLION RUPEES YEAR AGO.SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.56 BILLION RUPEES VERSUS 4.35 BILLION RUPEES YEAR AGO.

J B Chemicals And Pharmaceuticals Approves 1.30 Bln Rupee-Share Buyback

Nov 12 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::APPROVED BUYBACK OF UP TO 3 MILLION SHARES FOR NOT EXCEEDING 1.30 BILLION RUPEES.

J B Chemicals And Pharmaceuticals Says Board To Consider Buy-Back Of Equity Shares

Nov 6 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::J B CHEMICALS AND PHARMACEUTICALS LTD SAYS BOARD TO CONSIDER BUY-BACK OF EQUITY SHARES.

India's J B Chemicals And Pharmaceuticals June-Qtr Consol Net Profit Rises

Aug 13 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::JUNE QUARTER CONSOL NET PROFIT 620.1 MILLION RUPEES VERSUS 456.3 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 4.46 BILLION RUPEES VERSUS 4.07 BILLION RUPEES YEAR AGO.

India's J B Chemicals And Pharmaceuticals March Qtr Net PAT Rises

May 21 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::MARCH QUARTER NET PAT 421.8 MILLION RUPEES VERSUS PROFIT 220.6 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 3.79 BILLION RUPEES VERSUS 3.18 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 5 RUPEES PER SHARE.

India's J B Chemicals And Pharmaceuticals Dec Qtr Net PAT Rises

Feb 8 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::DEC QUARTER NET PAT 463.7 MILLION RUPEES VERSUS PROFIT 338.5 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 3.52 BILLION RUPEES VERSUS 3.05 BILLION RUPEES YEAR AGO.

J B Chemicals And Pharmaceuticals Expects Loss Of About 50 Mln Rupees Due To Explosion At Panoli

Nov 5 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::J B CHEMICALS AND PHARMACEUTICALS-INSURANCE CLAIM IN RESPECT OF LOSS DUE TO EXPLOSION AT PANOLI FACILTY IS 260.7 MILLION RUPEES.SAYS INCIDENT DOES NOT HAVE MATERIAL IMPACT ON MANUFACTURING AND SALES ACTIVITIES.J B CHEMICALS - SEES LOSS OF SALES OF ABOUT 50 MILLION RUPEES, INCUR ADDITIONAL COST OF ABOUT 2 MILLION RUPEES ON PROCUREMENT OF CERTAIN APLS DURING 2018-19.

J B Chemicals And Pharmaceuticals Says U.S. FDA Approves ANDA For Midodrine Hydrochloride Tablets USP

Nov 5 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::SAYS US FDA APPROVED COMPANY'S ANDA FOR MIDODRINE HYDROCHLORIDE TABLETS USP.PLANS TO COMMERCIALIZE PRODUCT IN Q 1 OF NEXT FINANCIAL YEAR.

India's J B Chemicals And Pharmaceuticals Sept-Qtr Net PAT Falls

Nov 2 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::SEPT QUARTER NET PROFIT AFTER TAX 514.4 MILLION RUPEES VERSUS PROFIT 517.2 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 4.04 BILLION RUPEES VERSUS 3.47 BILLION RUPEES YEAR AGO.

J B Chemicals And Pharmaceuticals Says Co Went Through US FDA Pre-Approval Inspection

Oct 19 (Reuters) - J B Chemicals and Pharmaceuticals Ltd <JBCH.NS>::CO WENT THROUGH US FDA PRE-APPROVAL INSPECTION FOR ANDA FILED FOR A CAPSULE PRODUCT.POST INSPECTION, USFDA ISSUED 4 MINOR OBSERVATIONS; CO PROPOSES TO ADDRESS THESE OBSERVATIONS WITHIN NEXT 15 DAYS.SAYS OBSERVATIONS WILL NOT HAVE ANY IMPACT ON CURRENT BUSINESS.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up